0.9999

2.03% 0.0199

After Hours: 1.00 0.000100 +0.01%

Kronos Bio Inc (KRON)

Overview News Price History Option Chain Financials Discussions Forecast

Kronos Bio Inc stock is traded at $0.9999, with a volume of 59,963. It is up +2.03% in the last 24 hours and down -4.77% over the past month. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Previous Close:

$0.98

Open:

$0.97

24h Volume:

59,963

Relative Volume:

0.41

Market Cap:

$59.67M

Revenue:

Net Income/Loss:

$-112.67M

P/E Ratio:

-0.4739

EPS:

-2.11

Net Cash Flow:

$-79.26M

1W Performance:

-0.01%

1M Performance:

-4.77%

6M Performance:

-23.08%

1Y Performance:

-23.08%

1-Day Range:

$0.9547

$1.01

1-Week Range:

$0.9301

$1.03

52-Week Range:

$0.69

$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Name

Kronos Bio Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

(650) 781-5200

Address

1300 S. EL CAMINO REAL, SAN MATEO

Employee

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

KRON's Discussions on Twitter

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-14-22	Initiated	Berenberg	Buy
Oct-20-21	Resumed	Cowen	Outperform
Jun-24-21	Initiated	H.C. Wainwright	Buy
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Goldman	Buy
Nov-03-20	Initiated	Jefferies	Buy
Nov-03-20	Initiated	Piper Sandler	Overweight

View All

Kronos Bio Inc Stock (KRON) Latest News

Sep 29, 2024

Kronos Bio, Inc. (NASDAQ:KRON) Position Increased by Forefront Analytics LLC - Defense World

Sep 29, 2024

Sep 25, 2024

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy - StockTitan

Sep 25, 2024

Avoro Capital Advisors LLC Reduces Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Sep 23, 2024

Integral Health Asset Management LLC Acquires 45,000 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Sep 23, 2024

How the (KROS) price action is used to our Advantage - Stock Traders Daily

Sep 23, 2024

How does Keros Therapeutics Inc (KROS) change from a tortoise to a hare? - SETE News

Sep 23, 2024

Kronos Bio highlights istisociclib data at Ovarian Cancer Research Symposium - TipRanks

Sep 23, 2024

71,428 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Acquired by Tri Locum Partners LP - MarketBeat

Sep 23, 2024

Kronos Bio Highlights Data at AACR Ovarian Cancer Research - GlobeNewswire

Sep 23, 2024

Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer - StockTitan

Sep 23, 2024

Keros Therapeutics (NASDAQ:KROS) Receives New Coverage from Analysts at Guggenheim - MarketBeat

Sep 23, 2024

Guggenheim starts Keros Therapeutics with 'buy' on lung disorder drug potential - XM

Sep 23, 2024

Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects - Investing.com Australia

Sep 23, 2024

Sep 22, 2024

Gogo Inc. (NASDAQ:GOGO) Shares Sold by Yarra Square Partners LP - Defense World

Sep 22, 2024

American Century Companies Inc. Has $13.63 Million Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Sep 22, 2024

Sep 21, 2024

Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Bought by Rhumbline Advisers - Defense World

Sep 21, 2024

Sep 19, 2024

Pharmacosmos after major acquisition: “The next six months are about integrating G1 well” - MedWatch

Sep 19, 2024

Sep 18, 2024

Understanding CRON stock ratios for better investment decisions - US Post News

Sep 18, 2024

DekaBank Deutsche Girozentrale Has $4.25 Million Holdings in Dollar Tree, Inc. (NASDAQ:DLTR) - Defense World

Sep 18, 2024

Kronos Bio, Inc. (NASDAQ:KRON) Short Interest Update - MarketBeat

Sep 18, 2024

Sep 16, 2024

ABIVAX Société Anonyme (NASDAQ:ABVX) Sees Large Growth in Short Interest - Defense World

Sep 16, 2024

Sep 10, 2024

After Plunging -5.53% in 4 Weeks, Here's Why the Trend Might Reverse for Kronos Bio (KRON) - Yahoo Finance

Sep 10, 2024

Sep 03, 2024

Kronos Bio Announces Participation in Medical and Investor Conferences in September - Marketscreener.com

Sep 03, 2024

Kronos Bio Announces Participation in Medical and Investor Conferences in September - GlobeNewswire

Sep 03, 2024

Kronos Bio Announces Participation in Medical and Investor Conferences in September - Yahoo Finance

Sep 03, 2024

Sep 02, 2024

The Psychology of Kronos Bio Inc Inc. (KRON) Price Performance: Understanding Market Sentiment - The InvestChronicle

Sep 02, 2024